AstraZeneca
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus
- First Posted Date
- 2006-04-12
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 12
- Registration Number
- NCT00313183
- Locations
- 🇺🇸
Research Site, New York, New York, United States
A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas
- Conditions
- Interventions
- First Posted Date
- 2006-04-12
- Last Posted Date
- 2015-05-04
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 768
- Registration Number
- NCT00313313
- Locations
- 🇺🇸
Stewart Medical Group, Alhambra, California, United States
🇺🇸Valley Research, Fresno, California, United States
🇺🇸Randall Shue, D.O., Los Angeles, California, United States
Effect of Roflumilast on Lung Function in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Salmeterol: The EOS Study (BY217/M2-127)
- Conditions
- Interventions
- First Posted Date
- 2006-04-12
- Last Posted Date
- 2016-12-14
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 933
- Registration Number
- NCT00313209
- Locations
- 🇿🇦
Altana Pharma/Nycomed Investigational Sites, Kapstadt, South Africa
🇬🇧Altana Pharma/Nycomed Investigational Site, Watford, United Kingdom
Study of Ticilimumab in Patients With Metastatic Colorectal Cancer Whose Disease Had Progressed After Treatment
- First Posted Date
- 2006-04-12
- Last Posted Date
- 2012-06-07
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 49
- Registration Number
- NCT00313794
- Locations
- 🇨🇦
Research Site, Quebec, Canada
Randomized Study Of CP-675,206 or Best Supportive Care Immediately After Platinum-Based Therapy For Non-Small Cell Lung Cancer (NSCLC)
- Conditions
- Interventions
- First Posted Date
- 2006-04-11
- Last Posted Date
- 2012-06-07
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 90
- Registration Number
- NCT00312975
- Locations
- 🇬🇧
Research Site, London, United Kingdom
Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)
- Conditions
- Interventions
- First Posted Date
- 2006-03-29
- Last Posted Date
- 2015-08-26
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 303
- Registration Number
- NCT00308139
- Locations
- 🇨🇦
Research Site, Toronto, Ontario, Canada
🇺🇸Research Site 023, Butte, Montana, United States
🇺🇸Research Site 518, San Diego, California, United States
Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentin™)
- First Posted Date
- 2006-03-27
- Last Posted Date
- 2012-11-01
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 60
- Registration Number
- NCT00306891
- Locations
- 🇬🇧
Research Site, Manchester, United Kingdom
Use of Quetiapine as an Add on Therapy in the Treatment of Post Traumatic Stress Disorder
- Conditions
- Interventions
- First Posted Date
- 2006-03-24
- Last Posted Date
- 2010-12-09
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 90
- Registration Number
- NCT00306540
- Locations
- 🇦🇺
Research Site, Melbourne, Victoria, Australia
Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101)
- First Posted Date
- 2006-03-23
- Last Posted Date
- 2017-02-01
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 37
- Registration Number
- NCT00306163
- Locations
- 🇳🇱
Altana Pharma/Nycomed, RB Groningen, Netherlands
Effect of Quetiapine on Negative Symptoms and Cognition
- Conditions
- First Posted Date
- 2006-03-22
- Last Posted Date
- 2009-06-11
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 45
- Registration Number
- NCT00305422
- Locations
- 🇩🇪
Research Site, Munich, Germany